These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 27125054)

  • 21. [Thoughts on the improvement of the quality of the drugs prepared in the pharmacy].
    Hädicke M
    Pharm Prax; 1966 Apr; 4():103-4. PubMed ID: 6001079
    [No Abstract]   [Full Text] [Related]  

  • 22. GMPs vs GCPs: manufacturing and compounding definitions.
    Allen LV
    Int J Pharm Compd; 2013; 17(5):356. PubMed ID: 24459778
    [No Abstract]   [Full Text] [Related]  

  • 23. Drug product quality.
    Exp Med Surg; 1971; 29(1):135-44. PubMed ID: 5147595
    [No Abstract]   [Full Text] [Related]  

  • 24. Survey of sterile product compounding practices in Canadian hospital pharmacies.
    Fitch DP; Hall KW
    Can J Hosp Pharm; 1993 Dec; 46(6):249-60. PubMed ID: 10131343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unlicensed pharmaceutical preparations for clinical patient care: Ensuring safety.
    de Wilde S; de Jong MGH; Le Brun PPH; Guchelaar HJ; Schimmel KJM
    Pharmacoepidemiol Drug Saf; 2018 Jan; 27(1):3-8. PubMed ID: 29047193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Compounding USP <797>: inspection, regulation, and oversight of sterile compounding pharmacies.
    Kastango ES
    JPEN J Parenter Enteral Nutr; 2012 Mar; 36(2 Suppl):38S-39S. PubMed ID: 22275322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety Standards in Pharmaceutical Compounding, Part 3: Fire Safety.
    Allen WC; Greeson NM; Mixon W
    Int J Pharm Compd; 2020; 24(6):451-458. PubMed ID: 33217734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organ Tech Rep Ser; 1999; 885():i-vi, 1-156. PubMed ID: 10352573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Practice of Compounding, Associated Compounding Regulations, and the Impact on Dermatologists.
    Quertermous J; Desai S; Harper J; Lebwohl M; Torres A; Kircik LH
    J Drugs Dermatol; 2018 Jul; 17(7):s17-s22. PubMed ID: 30005109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Final guidance for pharmacy compounding of human drug products under Section 503A.
    Blankenship CE
    Int J Pharm Compd; 2014; 18(5):379-80. PubMed ID: 25577886
    [No Abstract]   [Full Text] [Related]  

  • 31. Compounding practices in Iran.
    Goodarzi N; Niknam S; Akbarzadeh T; Gholami K
    Int J Pharm Compd; 2014; 18(2):112-6. PubMed ID: 24881113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Choosing a Vial Processing Line for Aseptic Compounding: Part 1.
    Noorian S; Vahedi N
    Int J Pharm Compd; 2016; 20(4):283-292. PubMed ID: 28333673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Root Cause Analysis, Part 1: Nonsterile Compounding.
    Cabaleiro J; Jackson K
    Int J Pharm Compd; 2015; 19(6):465-9. PubMed ID: 26891560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Compounding botanicals: a legal perspective.
    Valentino JG; Bormel FG
    J Am Pharm Assoc (Wash); 1999; 39(4):537-44. PubMed ID: 10467820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Causes and root causes of a multistate fungal meningitis outbreak.
    Lipowski EE; Smith WT; Navarro RP
    J Am Pharm Assoc (2003); 2015; 55(2):118. PubMed ID: 25616150
    [No Abstract]   [Full Text] [Related]  

  • 36. [Improving the quality of compounded medicines through self-assessment: proof of concept].
    Wauters K; Fierens C; Corthout J; Sarre S; Saevels J
    J Pharm Belg; 2014 Jun; (2):26-33. PubMed ID: 25055453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Norms for providing the Czechoslovak medical service with pharmaceuticals. 3. Preparation of galenic preparations in pharmacies].
    Solich J; Dofková L; Ajgelová J
    Cesk Farm; 1968 Sep; 17(7):342-8. PubMed ID: 5679399
    [No Abstract]   [Full Text] [Related]  

  • 38. A Simplified Method for Compounding Lidocaine Topical Gel: A Demonstration of Quality Assurance to Prevent Errors in 503A Pharmacies.
    Hall E; Levesque D; Rashid M; Mullins R; Hossain MF
    Int J Pharm Compd; 2021; 25(3):197-204. PubMed ID: 34125709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Description of outbreaks of health-care-associated infections related to compounding pharmacies, 2000-12.
    Staes C; Jacobs J; Mayer J; Allen J
    Am J Health Syst Pharm; 2013 Aug; 70(15):1301-12. PubMed ID: 23867487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improving and enforcing compounding pharmacy practices to protect patients.
    Pegues DA
    Clin Infect Dis; 2006 Oct; 43(7):838-40. PubMed ID: 16941363
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.